Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of aromatase inhibitors on insulin sensitivity, liver and heart function in obese men
2013-002964-22Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Oct 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of letrozole in obesity, sponsored by Ghent University Hospital. Primary endpoints: Change in insulin sensitivity, Change in liver function and 1 more. Started Oct 2013; status: completed.
02
Drugs
letrozole
03
Conditions
obesity
Beyond the preview
Go deeper on 2013-002964-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002964-22.